CordenPharma is a CDMO partner supporting biotech & pharma innovators of complex modalities in the advancement of their drug development lifecycle with bespoke outsourcing services from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, CordenPharma provides high-value, end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid Nanoparticles, sterile Injectables and Small Molecules.